Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
Sober living |
Lofexidine (0.2–0.8 mg/day) is a sympatholytic centrally acting α2 presynaptic adrenergic agonist that showed similar efficacy in some cases 23,65,66. It’s unclear how many people experience this condition because people with a history of recreational drug use may not feel comfortable admitting this to their doctor. Visual aberrations can occur periodically in healthy individuals – […]

Lofexidine (0.2–0.8 mg/day) is a sympatholytic centrally acting α2 presynaptic adrenergic agonist that showed similar efficacy in some cases 23,65,66. It’s unclear how many people experience this condition because people with a history of recreational drug use may not feel comfortable admitting this to their doctor. Visual aberrations can occur periodically in healthy individuals – e.g., afterimages after staring at a light, noticing floaters inside the eye, blue field entoptic phenomenon or seeing specks of light in a darkened room. However, in people with HPPD, symptoms seem typically to be worse, but complication comes from the additional roles played by anxiety and fixation. Indeed, anxiety has been implicated in visual perceptual effects similar to HPPD,17 and authors have recognized the crucial role of attending to underlying anxiety and panic in recovering from the disorder. The mechanisms behind HPPD are still not well understood, and there is a lack of clear explanation regarding its causes.
Treatment course
Auditory experiences, like loud music at a concert, may be more intense than normal. If a person is experiencing visual disturbances, they should speak to their doctor. It is also not the result of current intoxication or by an amount of a drug staying in a person’s system.
Which drugs cause HPPD?
Their symptoms improved significantly after treatment initiation and the improvement persisted during a 6-month follow-up after treatment discontinuation 51. The same author reported two cases of cannabis-induced visual disturbances and correlated anxiety features. In both cases, Clonazepam (2 mg/day) was effective in improving symptoms, but focal visual disturbances without anxiety (trailing phenomena in one case, and black moving spots in the second case) persisted during and after therapy 19. More recently, Clonazepam (6 mg/day) has been proved to be effective in improving cannabis-induced HPPD symptoms 50.
Available treatment options

Psychedelic integration therapy can also help people with HPPD make sense, re-address and start to make sense of the experience that triggered their disorder. Many people with HPPD also experience anxiety and depression, and in some cases, suicidal thoughts. Results from brain magnetic resonance imaging scans, median nerve somatosensory evoked potentials, electroencephalograms and visual evoked potential tests were all normal. Earlier in 2011, the patient underwent an 8-week course of psychosomatic treatment for depression as an outpatient at a university hospital clinic in southern Germany.
HPPD is different from other psychotic disorders because while hppd symptoms you’re having an episode, you’re aware of it, and you know that what you’re seeing isn’t real. Trails or tracers, or when the image of objects seem to linger even after they move, creating a repeated “trail” of the object as it moves. Or you may continue to see an object even after it’s gone from your vision (an “after image”). When you have one, the vision or experience of a past event springs into your mind suddenly. Often, these are negative events that feel intrusive, unwanted, and unpleasant. Lauterbach et al. reported the unique case of HPPD induced by the atypical antipsychotic Risperidone 60.

Such effects have been considered to be particularly important for people struggling with inflexible thought patterns involved in many mental health disorders. Today, studies and clinical trials on the efficacy of various psychedelic-assisted therapies are still in progress. But as clinical research centers, private investment in psychedelic drug development, and legal acceptance continue to expand across the US and other countries, medical knowledge about psychedelic therapy Halfway house is developing quickly. With research that is currently available, it is strongly suggested that psychedelic drugs have great potential to enhance treatments for various mental health conditions. An estimated 5.5 million adults in the United States use hallucinogenic drugs. People who take hallucinogens may be hoping to escape their lives, reset their brains or have new experiences.
- The primary risk factor for HPPD disorder is using LSD and other hallucinogenic drugs.
- Such goals may range from addressing specific traumatic experiences to gaining insights into personal patterns and behaviors.
- The use of second-generation antipsychotics in HPPD patients without comorbid psychotic disorders is debated.
- However, they do not yet understand the type or frequency of drug use that causes it.
- If one of our articles is marked with a ‘reviewed for accuracy and expertise’ badge, it indicates that one or more members of our team of doctors and clinicians have reviewed the article further to ensure accuracy.
- There are questionable and controversial results regarding Sertraline, which has been reported to worsen 81 as well as to improve visual disturbances.
- Furthermore, lamotrigine is generally well tolerated with a relative lack of adverse effects, making it a drug of choice for youths and young adults.
- One theory of why psychedelics cause visual hallucinations is that they stop information incoming into the visual cortex from being filtered out.
- The therapeutic guide is present during either much or all of the session to help the patient remain open and attentive to these emotional and experiential elements of the drug’s effects.
- People with Hallucinogen Persisting Perception Disorder re-experience the same hallucinations they had on a past psychedelic “trip.” Oftentimes, these hallucinations are visual but they can affect the other senses as well.
Often the patient was unable to focus properly with her eyes and tired rapidly while performing intense visual tasks – these deficiencies being detrimental to her studies and professional work as an architect. As a consequence, the patient became depressed with latent suicidal impulses. She also found it increasingly difficult to distinguish between ‘normal’ and ‘ abnormal’ perceptions.

How we reviewed this article:
The primary risk factor for HPPD disorder is using LSD and other hallucinogenic drugs. The Perception Restoration Foundation (PRF) is an industry-funded 501 nonprofit. However, reports have highlighted that other psychoactive drugs which aren't classically psychedelic, such as MDMA, ketamine, and cannabis, can onset HPPD. Furthermore, certain medications have elicited HPPD-style changes, including antidepressants, antibiotics, and antipsychotics. These symptoms persisted for the last 13 years, with little change in intensity and frequency. All efforts at treatment, psychopharmacological as well as psychotherapeutic, failed to alleviate the symptoms.